SureTrader
Home > Boards > US Listed > Biotechs >

Alexza Pharmaceuticals Inc. (ALXA)

ALXA RSS Feed
Add ALXA Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 2/4/2016 11:22:07 AM - Followers: 77 - Board type: Free - Posts Today: 0

 

Alexza Pharmaceuticals Inc.


Revolutionary Technology

Revolutionary Technology


Alexza Pharmaceuticals is a rapidly emerging pharmaceutical company focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system, or CNS conditions. All of our product candidates are based on our proprietary technology, the Staccato® system. The Staccato system vaporizes excipient-free drugs to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. Because of the ideal particle size of the aerosol, the pure drug is quickly absorbed through the deep lung into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous (IV) administration but with greater ease, patient comfort and convenience.

Alexza's lead program is ADASUVE (Staccato loxapine or AZ-004), being developed for the acute treatment of agitation in patients with schizophrenia or bipolar disease. During 2011, Alexza resubmitted the ADASUVE NDA and the ADASUVE MAA in Europe.  Alexza has a U.S. PDUFA goal date for ADASUVE of February 4, 2012.






 

 

Staccato nicotine (Preclinical)

http://www.alexza.com/
http://finance.yahoo.com/q/ks?s=ALXA

Alexza Pharmaceuticals, Inc., a development stage company, focuses on the development and commercialization of products for the treatment of acute and intermittent conditions primarily in the United States. Its technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The company has four product candidates in clinical development: AZ-001 (Staccato prochlorperazine) for the acute treatment of migraine headaches; AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder; AZ-004 (Staccato loxapine) for the treatment of acute agitation in patients with schizophrenia; and AZ-003 (Staccato fentanyl) for the treatment of patients with acute pain. Its product candidate AZ-001 completed Phase IIb Clinical Trial; AZ-004 completed Phase IIa Clinical Trial; AZ-002 is in Phase IIa Clinical Trials; and AZ-003 completed a Phase I Clinical Trial. Alexza Pharmaceuticals has a development agreement with Autoliv ASP, Inc. for the development of heat packages that can be incorporated into proprietary single dose drug delivery device. The company, formerly known as FaxMed, Inc., was founded in 2000. FaxMed changed its name to Alexza Corporation in June 2001 and to Alexza Molecular Delivery Corporation in December 2001. Further, it changed its name to Alexza Pharmaceuticals, Inc. in July 2005. The company is based in Palo Alto, California.

Biography Photo Thomas B. King
President, Chief Executive Officer

Thomas B. King has served as our President, Chief Executive Officer and a member of our Board since June 2003. From September 2002 to April 2003, Mr. King served as President, Chief Executive Officer and a member of the board of directors of Cognetix, Inc., a biopharmaceutical development company. From January 1994 to February 2001, Mr. King held various senior executive positions, including President and Chief Executive Officer from January 1997 to October 2000, and was a member of the board of directors at Anesta Corporation, a publicly traded pharmaceutical company, until it was acquired by Cephalon, Inc., a publicly traded biopharmaceutical company. Mr. King received an M.B.A. from the University of Kansas and a B.A. in chemistry from McPherson College.



[

 


 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ALXA
Current Price
Volume:
Bid Ask Day's Range
Wiki
ALXA News: Current Report Filing (8-k) 01/22/2016 04:18:42 PM
ALXA News: Statement of Changes in Beneficial Ownership (4) 01/19/2016 05:13:19 PM
ALXA News: Current Report Filing (8-k) 12/22/2015 05:15:42 PM
ALXA News: Alexza Pharmaceuticals Announces Receipt of NASDAQ Staff Determination; Alexza to Request Hearing with NASDAQ Listing Qualifi... 12/22/2015 05:00:00 PM
ALXA News: Current Report Filing (8-k) 12/21/2015 04:23:15 PM
PostSubject
#3159   Timber CarlCarlMcB 02/04/16 11:22:07 AM
#3158   .00001 CarlCarlMcB 01/16/16 10:33:13 AM
#3157   Coooooovvvver your shorts u are in trouble now marina22 01/16/16 08:42:09 AM
#3156   Will see .01 now CarlCarlMcB 01/16/16 08:37:46 AM
#3155   Even more WRONG marina22 01/16/16 08:37:01 AM
#3154   Wrong marina22 01/16/16 08:34:51 AM
#3153   .10 CarlCarlMcB 01/07/16 03:57:43 PM
#3152   Sadness. Not much to take this down over presence 01/06/16 10:54:40 AM
#3151   .25 CarlCarlMcB 12/28/15 11:12:02 AM
#3150   Very small float, we should see at least T695 12/22/15 09:57:44 AM
#3149   Wish I was able to short from T695 12/22/15 09:54:33 AM
#3148   Long T695 12/22/15 09:49:42 AM
#3147   long or short? [SMART MONEY] 12/22/15 09:47:27 AM
#3146   In at .92 T695 12/22/15 09:41:36 AM
#3145   Starting to look like a great short, no T695 12/22/15 08:03:41 AM
#3144   OK SO MAYBE I SHOULD SHORT THIS bonappetite85 12/22/15 07:59:33 AM
#3143   Was only about $14k in after hours sales. T695 12/22/15 07:58:09 AM
#3142   I sold all my shares such a dope...look bonappetite85 12/22/15 07:56:34 AM
#3141   The way it's being bid up on such T695 12/22/15 07:54:03 AM
#3140   HOLY COW this is going to be $5.00 bonappetite85 12/21/15 05:08:33 PM
#3139   :-) T695 12/21/15 04:37:30 PM
#3138   This was an interesting move on Alexza's part. Scifi1 11/02/15 09:10:11 AM
#3137   Yes, I agree the potential to have the operating_line 10/31/15 04:46:57 AM
#3136   I think the "allow the use of the Scifi1 10/30/15 10:28:44 AM
#3135   DOWN BUT NOT OUT: Solid Press Release operating_line 10/14/15 10:58:36 AM
#3134   MOUNTAIN VIEW, Calif., Sept. 28, 2015 /PRNewswire/ -- operating_line 10/08/15 09:21:58 AM
#3133   remember this was $5.00 caliing.45-bottom-and-will-sit-there chris12 05/21/15 08:15:53 AM
#3132   Sounds like some key board members left the alphaInvestor2 05/19/15 02:16:58 PM
#3131   When this breaks $1/share this will fall off alphaInvestor2 05/19/15 01:20:22 PM
#3130   poor financials, technical support broke at 1.22/share, lack alphaInvestor2 05/19/15 01:12:20 PM
#3129   alphaInvestor2 05/19/15 01:07:19 PM
#3128   Could GAP DOWN HERE SELL SELL SELL! alphaInvestor2 05/19/15 01:05:21 PM
#3127   Could GAP DOWN HERE SELL SELL SELL! alphaInvestor2 05/19/15 01:05:21 PM
#3126   Wow, This one should keep falling below $1. alphaInvestor2 05/19/15 12:53:45 PM
#3125   Hey MacD! good man. lady glueck 01/17/15 07:31:02 PM
#3124   I do believe this one is in play. Penny Roger$ 01/13/15 04:25:34 PM
#3123   Someone left the cap off the bottle. Losing Penny Roger$ 01/13/15 04:23:56 PM
#3122   well... lady glueck 01/13/15 03:59:35 PM
#3121   What a nice move. All these bios going nuts Penny Roger$ 01/10/15 08:28:37 PM
#3120   $ALXA recent news/filings stocktrademan 08/10/14 12:51:29 PM
#3119   This is odd.....even for Alxa. What's with the Scifi1 05/21/14 03:27:12 PM
#3118   Worst performing stock I've held up to now. Scifi1 04/11/14 08:08:34 AM
#3117   Wow. Just checking in here after not having imperativity 04/10/14 08:02:29 PM
#3116   Taking a beating here. Looks like just about Scifi1 04/07/14 02:32:57 PM
#3115   Very kind of you. Scifi1 02/27/14 03:47:36 PM
#3114   Let me fix that for you: Boxsterfan 02/27/14 12:05:20 PM
#3113   I'm anticipating it's the partnership deal....But, this being Scifi1 02/26/14 11:51:42 AM
#3112   Yes it has been a quiet run up, Scifi1 02/26/14 11:33:10 AM
#3111   ALXA is simply preparing to dilute. They have Boxsterfan 02/26/14 11:23:20 AM
#3110   Nice quiet run recently MasterJ 02/25/14 05:42:55 PM
PostSubject